AU5856596A - Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion - Google Patents

Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion

Info

Publication number
AU5856596A
AU5856596A AU58565/96A AU5856596A AU5856596A AU 5856596 A AU5856596 A AU 5856596A AU 58565/96 A AU58565/96 A AU 58565/96A AU 5856596 A AU5856596 A AU 5856596A AU 5856596 A AU5856596 A AU 5856596A
Authority
AU
Australia
Prior art keywords
inhibition
transcription factor
transcriptional activation
strand invasion
mediated transcriptional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58565/96A
Inventor
Timothy A Vickers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU5856596A publication Critical patent/AU5856596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003Peptide-nucleic acids (PNAs)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/15Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/152Nucleic acids forming more than 2 strands, e.g. TFOs on a single-stranded target, e.g. fold-back TFOs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/318Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C12N2310/3181Peptide nucleic acid, PNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3513Protein; Peptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU58565/96A 1995-05-10 1996-05-10 Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion Abandoned AU5856596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43837995A 1995-05-10 1995-05-10
US438379 1995-05-10
PCT/US1996/006673 WO1996035705A1 (en) 1995-05-10 1996-05-10 Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion

Publications (1)

Publication Number Publication Date
AU5856596A true AU5856596A (en) 1996-11-29

Family

ID=23740427

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58565/96A Abandoned AU5856596A (en) 1995-05-10 1996-05-10 Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion

Country Status (2)

Country Link
AU (1) AU5856596A (en)
WO (1) WO1996035705A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472209B1 (en) 1997-10-17 2002-10-29 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6723560B2 (en) 1998-10-08 2004-04-20 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
US6989270B1 (en) 1997-10-17 2006-01-24 Mayo Foundation For Medical Education And Research Using polyamide nucleic acid oligomers to engender a biological response
DE19757516A1 (en) * 1997-12-23 1999-06-24 Roche Diagnostics Gmbh New oligo-nucleotide analogs with negatively charged non-nucleoside units

Also Published As

Publication number Publication date
WO1996035705A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
AU3609097A (en) Retinoid inhibition of expression of VEGF
EP0783154A3 (en) Split-level graphics library
AU4915796A (en) Inhibitors of prenyl transferases
AU4570396A (en) Casting of metal
AU4919496A (en) Potentiators of antibacterial agents
AU6614696A (en) Inhibition of gene expression
AU3917595A (en) Continuous unloader
AU6525296A (en) Wound treatment composition
AU1090097A (en) Winch
AU6614596A (en) Inhibition of gene expression
AU7225496A (en) Self-medication device
AU695959B2 (en) Prodrugs of paclitaxel derivatives
AU6692996A (en) Inhibitors of apoptosis
AUPN141995A0 (en) Column hoists
AU6040296A (en) Methods of inducing bef-1 transcription factor
AU5856596A (en) Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion
AU6109096A (en) Methods of inhibiting melanoma
AU5537996A (en) Hookworm vaccine
AU6175596A (en) Methods of modulating nf-kb transcription factor
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU1339597A (en) Cable retractor
AU7000496A (en) Anti-inflammatory antisense drug
AU6832896A (en) Wound dressings
AU4615496A (en) Masonry anchor
AU5126298A (en) Inhibition of crib-biting